期刊文献+

中国汉族男性人群巨噬细胞移动抑制因子-173G/C基因多态性与原发性痛风的易感性研究

Relationship between macrophage migration inhibitory factor-173G/C polymorphism and susceptibility to gout in Chinese male population
原文传递
导出
摘要 目的探讨中国汉族男性人群巨噬细胞移动抑制因子(MIF)启动子区-173G/C(rs755622)基因多态性的分布与原发性痛风遗传易感性之间的关系。方法选取380例痛风患者和378名健康对照者,采用聚合酶链反应.序列特异性引物(PCR-SSP)技术,检测中国汉族男性人群中MIF启动子区-173G/C基因等位基因及基因型频率的遗传分布,HaMy-Weinberg检验确认标本的群体代表性后,采用χ2检验进行关联分析,采用t检验对MIF基因-173G/C位点基因多态性与痛风危险因素进行比较。结果痛风组MIF启动子区-173位点GG、GC、CC基因型的频率为62.1%(236个)、34.2%(130个)、3.7%(14个);健康对照组MIF启动子区-173位点GG、GC、CC基因型频率为66.5%(252个)、29.8%(113个)、3.7%(14个),2组之间比较差异无统计学意义(χ2=1.713,P=0.425)。痛风组等位基因G、C的频率分别为79.2%(602个)和20.8%(158个),健康对照组为81.4%(617个)和18.6%(141个),2组之间等位基因G、C频率的比较差异也无统计学意义(χ2=1.148,P=0.302)。将痛风组基因型分析为GG基因型与Gc基因型合并为GG±GC组,结果显示:GG±GC组与CC组之间年龄[(51±13)和(50±15)岁,t=0.369,P=0.712]、血糖[(7.1±8.8)和(6.1±1.2)mmol/L,t=0.352,P=0.725]、甘油三酯[(2.3±1.6)和(2.9±3.4)mmol/L,t=-1.207,P=0.228]、胆固醇[(5.3±1.2)和(5.7±1.4)mmol/L,t=-1.207,P=0.228]、尿素氮[(5.8±2.9)和(6.2±2.2)mmol/L,t=0.513,P=0.608]、肌酐[(92±52)和(84±17)μmol/L,t=0.537,P=0.592]、尿酸[(472±103)和(557±154)μmol/IJ,t=-2.949,P=0.03]比较差异均无统计学意义(均P〉0.05)、经t检验,MIF基因-173G/C基因多态性位点与痛风病危险因素之间无相关性(乃0.05o结论中国汉族男性人群中MIF基因启动子区-173G/C基因多态性与痛风易感性之间没有关联性。 Objective To explore gene polymorphism of the G/C genotype of -173G/C (rs755622) in the promoter of macrophage migration inhibitory factor (MIF) gene in male population, and thus to investigate the relationship between gene polymorphism of MIF and gout. Methods A total of 380 gout patients and 378 healthy controls were enrolled. The possible assoeiad0n between the polymorphism of MIF -173G/C and gout in Chinese were investigated and genotype frequencies itnd allelic frequencies were analyzed by polymerase chain reaction with sequence-specific primers (PCR-SSP) method. Hardy-Weinberg was used to verify the representativeness of the samples. Comparisons between the groups were performed with X2 test. The gene polymorphism of MIF and gout was performed by t test. Results The frequencies of GG, GC, CC genotypes were 62.1%(236 eases), 34.2%(130 eases) and 3,7%(14 cases), respectively among gout patients, while they were 66.5%(252 cases), 29.8%( 113 cases) and 3.7%( 14 cases), respectively among the controls. There was no statistical difference in MIF -173G/C genotype frequencies between gout patients and controls (χ2= 1.713, P=0.425). The allele frequencies of G and C in gout cases were 79.2%(602 eases) and 20.8%(158 cases), while the controls were 81.4% (617 cases) and 18.6% (141 cases), and no significant difference between them could be found (χ2=-1.148, P=0.302). Combine GG and GC of gout into GG+GC, the association analysis of the two groups showed that, mean age, leves of glucose, TG, TC, BUN, Cr and UA of the GG+GC group and the CC group were (51±13) and (50±15)t=0.369, P=0.712; (7.1±8.8) and (6.1±1.2) mmol/L, t=0.352, P=0.725; (2.3±1.6) and (2.9±3.4) mmol/L,t=-1.207, P=0.228; (5.3±1.2) and (5.7±1.4) mmol/L, t=-1.207, P=0.228; (5.8+2.9) and (6.2±2.2) mmol/L, t=-0.513, P=-0.608; (92±52) and (84±17)μmol/L, t=0.537, P=0.592; (472±103) vs (557±154) μmol/L, t=-2.949, P=0.03 respectively; no significant difference was found in the two group. Moreover, no association between MIF -173G/C genotypes and risk factors for gout were detected in gout eases by t-test. Conclusion Results of the present study suggest that the G/C genotype of -173G/C in the promoter of MIF gene is not associated with gout in male population.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第10期692-695,共4页 Chinese Journal of Rheumatology
基金 国家自然科学基金(81070686,30570890,30871192)
关键词 巨噬细胞游走抑制因子 多态性 单核苷酸 痛风 Macrophage migration inhibitory factors Polymorphism, single nucleotide Gout
  • 相关文献

参考文献10

  • 1伍沪生.痛风研究 正逢其时[J].中华风湿病学杂志,2012,16(4):217-219. 被引量:6
  • 2Donn R, Alourfi Z, de Benedetti F. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum, 2002, 46: 2402-2409.
  • 3单志新,符永恒,余细勇,邓春玉,谭虹虹,林秋雄,于汇民,林曙光.巨噬细胞移动抑制因子-173G/C多态性与冠心病的相关性研究[J].中华医学遗传学杂志,2006,23(5):548-550. 被引量:19
  • 4Lee YH, Bae SC, Song GG. The association between the func- tional PTPN22 1858 C/T and MIF -173C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis. Inflam Res, 2012, 61: 411-415.
  • 5Przybylowska K, Mrowicki J, Sygut A. Contribution of the -173G/ C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases. Pol Przegl Chir, 2011, 83 : 76-80.
  • 6Li Y, Zeng Z, Deng S. Study of the relationship between human MIF level, MIF-794CATYS-8 microsatellite polymorphism, and susceptibility of tuberculosis in Southwest China. Braz J Infect Dis, 2012, 16: 383-386.
  • 7Wu SH, Lian JF, Tao HI. Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis. Oncol Lett, 2011, 2: 1261-1267.
  • 8吴杰,黄承滨,赵育桢,张丽秋,刘岸,傅松滨.MIF基因多态性及其与疾病关系的研究进展[J].国际遗传学杂志,2009,32(2):115-119. 被引量:6
  • 9尹丛丛,任山,赵迎春,李长贵,任伟,刘世国.中国沿海地区汉族男性人群白细胞介素-1β-511C/T基因多态性与痛风的易感性研究[J].中华风湿病学杂志,2012,16(4):264-267. 被引量:3
  • 10Busso N, So A. Mechanisms of inflanmmtion in gout. Arthritis Res Ther, 2010, 12: 206.

二级参考文献85

  • 1施桂英.痛风——降尿酸治疗的新策略[J].中华风湿病学杂志,2007,11(3):129-131. 被引量:21
  • 2Calandra T, Bemhagen J, Mitchell RA, et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med, 1994, 179:895-902.
  • 3Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol, 2003, 3:791- 800.
  • 4Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature, 2000, 408:211-216.
  • 5Lue HQ, Kleemann R, Calandra T, et al. Macrophage migration Inhibitory Factor (MIF) : mechanisms of action and role in disease. Microbes Infection, 2002, 4:449-460.
  • 6Roger T, David J, Glauser MP, et al. MIF regulates innate immune responses thorugh modulation of Toll-like reporte4. Nature, 2001,414:920-924.
  • 7Nishihira J, Ishibashi T, Fukushima T, et al. Macrophage migration inhibitory factor(MIF) : Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci, 2003, 995: 171-182.
  • 8Chesney J, Metz C, Baeher M, et al. An essential role for Maerophage Migration inhibitory fector (MIF) in angiogenesis and the growth of amurine lymphoma. Mol Med, 1999,5:181-191.
  • 9Clark NM, Gong M, chork MA, et al. Eongterm effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J, 2000, 16:15-21.
  • 10Bernhagen J, Calandra T, Bucala R. Regulation of the immune response by macrophage migration inhibitory factor: biological and structure features. J Mol Med, 1998, 76 : 1512-1611.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部